Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of ...
Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results